Innovating for Individual Care: The Impact of USP on Personalized Medicine
Quality Matters
MARCH 1, 2024
Innovating for Individual Care: The Impact of USP on Personalized Medicine In 2022, personalized medicines (PM) made up more than 34% of new therapeutics approved by the Food and Drug Administration (FDA). This is the subset of patients who could benefit the most from PM.
Let's personalize your content